UK regulator suspends Tavneos use for new patients
Britain’s medicines regulator suspended the use and sale of Amgen’s Tavneos to new patients, citing that the main study supporting approval was unreliable.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
UK regulator suspends Amgen’s Tavneos for new patients
Britain’s medicines regulator suspended the use and sale of Amgen’s rare-disease drug Tavneos to new patients, saying the main study supporting its approval was unreliable.